Schedule 13G filing

Two Seas Capital LP disclosed a 9.8% stake in Nektar Therapeutics (NKTR)

Schedule 13G · Filed Sep 28, 2026

Two Seas Capital LP reported owning 9.8% of Nektar Therapeutics (NKTR) (3,345,978 shares) in a Schedule 13G filed Sep 28, 2026.

A 13G is a passive stake: the holder does not plan to push for changes.

Stake

Nektar Therapeutics

Stake

9.8% stake

More NKTR insider and Congress trades

Share this trade

From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.